Efficacy of lycopene on modulation of renal antioxidant enzymes, ACE and ACE gene expression in hyperlipidaemic rats.
BACKGROUND
We aimed to evaluate the efficacy of lycopene on renal tissue antioxidant enzymes and angiotensin converting enzyme (ACE) gene expression and serum activity in diet-induced hyperlipidaemia.


METHODS
Thirty-two female Wistar albino rats (200-250 g weight), 5-6 months of age, were randomly selected and divided into four groups. Group I received normal diet; group II received 24 g high fat diet/100 g of daily diet; group III received 24 g high fat diet/100 g daily diet and 200 ml of lycopene extract (twice a week) for 8 weeks; and group IV received 200 ml oral lycopene extract twice a week for 8 weeks.


RESULTS
A marked increase was observed in plasma urea and creatinine levels, serum C-reactive protein, kidney weight, tissue renal malonyldialdehyde level, ACE gene expression and serum level, while a decrease catalase level among hyperlipidaemic rats was observed. Histologically, interstitial inflammation and proliferation was seen. Lycopene supplementation significantly decreased plasma urea and creatinine, serum ACE, renal tissue malonyldialdehyde level and C-reactive protein level, while it increased tissue antioxidant enzymes level and total protein. Tissue inflammation and proliferation was improved.


CONCLUSIONS
This finding suggests that supplementation of lycopene is effective for renal antioxidant enzymes, ACE gene expression and ACE serum level in hyperlipidaemic rats.
Department of Physiology, University of Karachi, Pakistan.
Nazish Iqbal
NI
Khan
Department of Biochemistry, Muhammad Bin Qasim Medical and Dental College, Pakistan.
Shafaq
S
Noori
Department of Biochemistry, University of Karachi, Pakistan tab60@hotmail.com.
Tabassum
T
Mahboob
Lycopene; angiotensin converting enzyme; hyperlipidaemia
Phytochemistry. 2000 Jun;54(3):233-6
10870177
Am J Nephrol. 2004 Jan-Feb;24(1):46-53
14707435
Methods Enzymol. 1996;268:237-46
8782590
J Am Coll Cardiol. 2010 Jun 22;55(25):2846-54
20579542
J Postgrad Med. 2013 Jan-Mar;59(1):30-41
23525056
J Complement Integr Med. 2016 Mar;13(1):9-16
26595408
Atherosclerosis. 2001 Aug;157(2):491-4
11472751
J Exp Bot. 2002 Oct;53(377):2107-13
12324534
J Nutr. 2006 Sep;136(9):2331-7
16920850
Endocr Rev. 2003 Jun;24(3):261-71
12788798
J Am Coll Cardiol. 2010 Mar 30;55(13):1283-99
20338488
Clin Chem. 1974 Nov;20(11):1458-60
4421368
Z Klin Chem Klin Biochem. 1974 Apr;12(4):146-50
4428836
Nephron. 1989;53(4):325-9
2601799
J Mol Cell Cardiol. 1999 Jan;31(1):51-60
10072715
Anal Biochem. 1979 Jun;95(2):351-8
36810
Iran J Basic Med Sci. 2015 Oct;18(10):1034-43
26730340
Coron Artery Dis. 1996 May;7(5):371-5
8866203
N Engl J Med. 1998 Jun 4;338(23):1650-6
9614255
J Lipid Res. 2004 May;45(5):881-8
14993241
Eur J Clin Pharmacol. 2003 Mar;58(11):719-31
12634978
J Renin Angiotensin Aldosterone Syst. 2012 Sep;13(3):328-33
22588536
J Toxicol Pathol. 2013 Sep;26(3):293-9
24155562
Mayo Clin Proc. 2010 Apr;85(4):349-56
20360293
Arch Biochem Biophys. 1978 Feb;186(1):189-95
24422
Cardiovasc Res. 2003 Jan;57(1):238-43
12504834
Circulation. 2001 May 29;103(21):2531-4
11382718
Annu Rev Physiol. 1992;54:227-41
1562174
Rev Assoc Med Bras (1992). 2016 Jan-Feb;62(1):45-7
27008492
Urology. 2003 Aug;62(2):353-6
12893363
Klin Wochenschr. 1965 Feb 1;43:174-5
14258517
Ann Clin Biochem. 1989 Jan;26 ( Pt 1):13-8
2544134
Methods Enzymol. 1985;113:484-90
3003504
J Renin Angiotensin Aldosterone Syst. 2006 Mar;7(1):3-14
17083068
Genet Test. 2007 Winter;11(4):353-9
18294050
J Vasc Res. 2005 Nov-Dec;42(6):475-82
16155363
Clin Cardiol. 1993 Apr;16(4 Suppl 1):I10-3; discussion I13-5
8472392
J Clin Chem Clin Biochem. 1983 Nov;21(11):709-20
6655447
Anal Biochem. 1972 Jun;47(2):389-94
4556490